Keywords: پسوریازیس; Psoriasis; Bayesian segmentation; Color features; Texture features; Machine learning; Performance evaluation;
مقالات ISI پسوریازیس (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پسوریازیس; Tofacitinib; Psoriasis; Lipoproteins; Lipid levels; Lipid metabolism; HDL function; Cardiovascular risk;
Keywords: پسوریازیس; Acitretin (PubChem CID:5284513); Methotrexate (PubChem CID:126941); DLQI; dermatology life quality index; ELISA; enzyme linked immunosorbent assay; IL; interleukin; PASI; psoriasis area and severity index; qRT-PCR; quantitative real-time polymerase chain
Keywords: پسوریازیس; APC; antigen presenting cell; DLS; dynamic light scattering; PFA; paraformaldehyde; COX; cycloxygenase; LOX; lipoxygenase; LPS; lipo poly saccharide; FBS; fetal bovine serum; IMQ; imiquimod; SOD; superoxide dismutase; MDA; malon di-aldehyde; GSH; glutathi
Keywords: پسوریازیس; psoriasis; complementary medicine; traditional; black cumin; topical treatment;
Keywords: پسوریازیس; Recherche fondamentale; Dermatologie; Psoriasis; Dermatite atopique; Microbiote; Immunité cutanée; Basic research; Dermatology; Psoriasis; Atopic dermatitis; Microbiote; Skin immune response;
Keywords: پسوریازیس; ILC; Skin; Atopic dermatitis; Psoriasis; Allergic contact dermatitis; Filaggrin;
Keywords: پسوریازیس; copy number variations; human β-defensin; polymorphisms; psoriasis
Keywords: پسوریازیس; biological therapy; psoriasis; ustekinumab; ADA; antidrug antibodies; DLQI; Dermatology Life Quality Index; PASI; Psoriasis Area and Severity Index;
Keywords: پسوریازیس; Psoriasis; Psoriatic arthritis; Cardiovascular risk factors; Age at disease onset
Keywords: پسوریازیس; Coronary flow reserve; Coronary microcirculation; Inflammation; Risk factors; Psoriasis;
Keywords: پسوریازیس; Biologics; Healthcare policy; Prevalence; Payer; Psoriasis; Psoriatic arthritis;
Keywords: پسوریازیس; Anxiety; Depression; Psoriasis; Quality of life;
Keywords: پسوریازیس; clinical trial; international; postmarketing surveillance; psoriasis; rare dermatologic disease; research;
Keywords: پسوریازیس; Psoriasis; Phototherapy; Systemic inflammation; Cytokines; Peripheral blood mononuclear cells;
Keywords: پسوریازیس; Psoriasis; Subclinical cardiovascular disease; Depression; Anxiety; Inflammation;
Keywords: پسوریازیس; health state utility; psoriasis; Psoriasis Area and Severity Index; quality of life; time trade-off; willingness to pay;
Keywords: پسوریازیس; AMAA; N-acetylmuramoyl-l-alanine amidase; COMP; cartilage oligomeric matrix protein; C3; complement factor C3; CK17; cytokeratin17; DSP; desmoplakin; HP; haptoglobin; JUP; junction plakoglobin; KLK8; kallikrein-8; KLKB1; plasma kallikrein; PIGR; polymeric
Keywords: پسوریازیس; Body image; Depression; Psoriasis; Stigma;
Keywords: پسوریازیس; Curcumin; Kv1.3 channel; Cytokine; Psoriasis;
Keywords: پسوریازیس; assessment of severity; cardiovascular disease; guidelines; metabolic syndrome; practice gaps; psoriasis; psoriatic arthritis; quality of life; AAD; American Academy of Dermatology; PsA; psoriatic arthritis; QOL; quality of life;
Keywords: پسوریازیس; Psoriasis; Psoriatic arthritis; Practice gaps; Treatment trends; Biologics; Resident education;
Keywords: پسوریازیس; Screening; Latent tuberculosis; Psoriasis; Biologic therapyDespistaje; Tuberculosis latente; Psoriasis; Terapia biológica
Keywords: پسوریازیس; burden; cost of care; hospitalization; inpatient; length of stay; mortality; psoriasis; racial disparities; CI; confidence interval; DRG; Diagnoses-Related Group; HCUP; Healthcare Cost and Utilization Project; ICD-9-CM; International Classification of Dis
Keywords: پسوریازیس; Adalimumab; Infliximab; Etarnecept; Ustekinumab; Psoriasis; Drugs therapies; Polymorphisms; Effectiveness;
Keywords: پسوریازیس; biologics; cost of care; hospitalization; length of stay; methotrexate; psoriasis; serious infection; CI; confidence interval; HCUP; Healthcare Cost and Utilization Project; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modi
Keywords: پسوریازیس; Psoriasis; Coexpression; WGCNA; System biology; Random forest; Classifier; Biomarker
Keywords: پسوریازیس; Riesgo cardiovascular; Síndrome metabólico; Psoriasis; Alopecia androgénica; Ovario poliquístico; Hidrosadenitis supurativaCardiovascular risk; Metabolic syndrome; Psoriasis; Androgenetic alopecia; Polycystic ovary syndrome; Hidradenitis suppurativa
Keywords: پسوریازیس; Microbiota; Microbiome; 16S rRNA; Metagenomics; Bacteria; Dysbiosis; Autoimmunity; Autoimmune disease; Inflammatory bowel disease; Psoriasis; Rheumatoid arthritis
Keywords: پسوریازیس; Homeopathy; Law of similars; Action mode of homeopathic remedies; Rebound effect; Paradoxical reaction; Biological therapy; Monoclonal antibodies; TNF antagonists; Psoriasis;
Keywords: پسوریازیس; Psoriasis; Biologics; Psoriatic comorbidities; Psoriatic arthritis;
Keywords: پسوریازیس; IL-17; IL-22 family; IL-23; inflammation; Janus kinase; keratinocyte; psoriasis; phosphorylated signal transducer and activator of transcription; TH17Â cell; tofacitinib; AMP; Antimicrobial peptide; DC; Dendritic cell; DEFB4A; Defensin beta 4a; FDR; False
Keywords: پسوریازیس; Psoriasis; Imiquimod; Acarbose; Inflammation; Tr1 T cells; IL-10
Keywords: پسوریازیس; Consensus development conference; Methotrexate; PsoriasisConferencia de consenso; Metotrexato; Psoriasis
Keywords: پسوریازیس; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Inflammation;
Keywords: پسوریازیس; Psoriasis; Artritis psoriásica; Coste de la enfermedad; Revisión; Alemania; España; Francia; Italia; Reino UnidoPsoriasis; Psoriatic arthritis; Cost of disease; Review; Germany; Spain; France; Italy; United Kingdom
Keywords: پسوریازیس; Prokineticin2; Psoriasis; Interleukin-1; Angiogenesis; Inflammation; Cell proliferation;
Keywords: پسوریازیس; Psoriasis; Psoriatic arthritis; Cost of disease; Review; Germany; Spain; France; Italy; United KingdomPsoriasis; Artritis psoriásica; Coste de la enfermedad; Revisión; Alemania; España; Francia; Italia; Reino Unido
Keywords: پسوریازیس; biologic; cyclosporine; immunosuppressant; methotrexate; perioperative; psoriasis; psoriatic arthritis; tumor necrosis factor-alfa inhibitor; CI; confidence interval; IBD; inflammatory bowel disease; IFX; infliximab; IL; interleukin; MeSH; medical subject
Keywords: پسوریازیس; Pediatrics; Warts; Genodermatoses; Sweaty sock dermatitis; Psoriasis; Eczema;
Keywords: پسوریازیس; CHM; Chinese herbal medicine; CM; Chinese medicine; ZHYD; Zhong Hua Yi Dian CD-ROM; Psoriasis; Chinese medicine; Classical literature; Terminology; Scholastics;
Keywords: پسوریازیس; AD; atopic dermatitis; AMP; antimicrobial peptide and protein; IHC; immunohistochemistry; IL; interleukin; IVL; involucrin; KRT; keratin; LOR; loricrin; PS; psoriasis; Th1; T helper type 1; Th2; T helper type 2; Th17; T helper type 17; TS; tape stripping;
Keywords: پسوریازیس; Nail; Onychomycosis; Psoriasis; Older; Elderly; Geriatric; disease; Ungual;
Keywords: پسوریازیس; AD; atopic dermatitis; IF; immunofluorescence; ILC; innate lymphoid cell; Lin; lineage; NHS; normal human skin; Pso; psoriasis; TF; transcription factor; Th; T helper;
Keywords: پسوریازیس; Innate lymphoid cells; mucosal immunity; inflammatory bowel disease; allergy; asthma; psoriasis; tumor immunity; graft-versus-host disease; AD; Atopic dermatitis; ART; Antiretroviral therapy; γc; Common γ chain; CLP; Common lymphoid progenitor; cNK; Con
Keywords: پسوریازیس; Psoriasis; Insomnia; Obstructive sleep apnea; Restless legs syndrome; Pruritus; Psoriatic arthritis;
Keywords: پسوریازیس; Methotrexate toxicity; Psoriasis; Skin ulceration;
Keywords: پسوریازیس; adalimumab; alcoholism; dermatoethics; distributive justice; ethics; methotrexate; psoriasis; tumor necrosis factor-α inhibitor;
Keywords: پسوریازیس; Coal tar; Polycyclic aromatic hydrocarbons; Bladder cancer; Psoriasis; Eczema; Case-control;
Keywords: پسوریازیس; Prolactin; Psoriasis; Vitiligo; Alopecia areata